Cardiovascular protection from statins greatly outweighs the risk of muscle symptoms

Study shows longer-term benefit of one-month dual antiplatelet therapy after intervention
29 August 2022
Research reveals widespread use of ineffective COVID-19 treatments after FDA deauthorized their use
29 August 2022

Cardiovascular protection from statins greatly outweighs the risk of muscle symptoms

The known benefits of statin therapy in preventing cardiovascular disease, including heart attacks and strokes, outweigh the slightly increased risk of muscle symptoms, according to late breaking research presented in a Hot Line session on 29 August at ESC Congress 2022.

Comments are closed.